Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Mitoquinone mesylate

VitaminCoQ10 derivativeBest in the morningBest taken away from food

Useful mainly for middle-aged and older adults targeting a measured improvement in vascular function.

Quick decision guide

May help most

middle-aged and older adults targeting a measured improvement in vascular function

Common dosing range

5–20 mg/day (10 mg is a common standard)

When to expect effects

Weeks

Watch out for

limited long-term safety data; monitor INR if on warfarin

What is it

Mitoquinone mesylate, commonly known as MitoQ, is a synthetic compound that combines coenzyme Q10 (CoQ10) with a triphenylphosphonium (TPP) lipophilic cation. This modification allows it to accumulate specifically inside mitochondria, where it acts as a targeted antioxidant. It is sold as a dietary supplement for general health and is also studied for various conditions.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You are a middle-aged or older adult interested in vascular function markers
You want a mitochondria-targeted antioxidant and accept early evidence

Probably skip if

You expect proven benefits for neurodegeneration, fatigue, or longevity
You are pregnant or breastfeeding
You are on warfarin and cannot monitor INR

Evidence at a glance

vascular function in middle-aged and older adults

Limited Evidence
Effect
Improved endothelial function (flow-mediated dilation)
Best fit
middle-aged and older adults with age-related vascular stiffening
Time
Weeks

mitochondrial oxidative stress

Limited Evidence
Effect
Reduced oxidative-stress markers
Best fit
people interested in targeting mitochondrial oxidative stress
Time
Weeks

Evidence for 2 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

vascular function in middle-aged and older adults

Biomarker support
Limited Evidence

A randomized trial in middle-aged and older adults found that MitoQ improved endothelial function (flow-mediated dilation) and reduced an oxidative-stress marker, consistent with its mitochondria-targeted antioxidant mechanism. The measured outcomes are vascular and oxidative biomarkers, not cardiovascular events, so this is a biomarker effect that does not establish prevention of heart disease.

Effect size
Improved endothelial function (flow-mediated dilation)
Time to effect
Weeks
Best fit
middle-aged and older adults with age-related vascular stiffening
Less likely
young healthy adults with normal vascular function

Bottom line: Improves a vascular function biomarker in older adults; not shown to prevent cardiovascular events.

mitochondrial oxidative stress

Mechanism only
Limited Evidence

MitoQ's triphenylphosphonium cation concentrates it inside mitochondria, where it scavenges reactive oxygen species and is regenerated by the electron transport chain. Protective effects in conditions of mitochondrial oxidative stress are well documented in animal and laboratory models, with human outcome data still limited. Evidence here is largely mechanistic and biomarker-level.

Effect size
Reduced oxidative-stress markers
Time to effect
Weeks
Best fit
people interested in targeting mitochondrial oxidative stress
Less likely
people seeking treatment for a specific diagnosed disease

Bottom line: Mechanistically reduces mitochondrial oxidative stress, but human clinical-outcome evidence is still limited.

How it works

The TPP cation of MitoQ allows the molecule to be drawn into mitochondria, where the inner membrane's negative charge concentrates it several hundred-fold compared with cytosol. Inside mitochondria, it is reduced to the active ubiquinol form, which scavenges reactive oxygen species generated by the electron transport chain. After scavenging, it is regenerated by the electron transport chain to repeat its action. This targeted delivery is the main difference from standard CoQ10, which has limited mitochondrial accumulation. Animal and laboratory studies have shown protective effects in many conditions involving mitochondrial oxidative stress, including aging, cardiovascular disease, and neurodegeneration. Human clinical trials are growing but still limited.

How to take it

1. Typical dose
5–20 mg/day; 10 mg is a common commercial standard
2. Timing
once daily in the morning
3. With food
on an empty stomach (or with light food) to support absorption
4. How long to try
trial over several weeks; reassess based on goals

What to track

blood pressure if monitored
exercise tolerance
any nausea or GI upset
INR if on anticoagulants

1 commercial form

Compare the main delivery options and what they’re best suited for.

MitoQ (mitoquinone mesylate) capsules

The standard commercial form. Typically 10 mg per capsule.

Mitochondria-targeted via lipophilic cation

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

nauseamild GI upsetrarely skin reactions

Who should avoid it

  • pregnant or breastfeeding women (insufficient data)
  • people on chemotherapy or with serious conditions without clinician input

Pregnancy & breastfeeding

Insufficient data; avoid or consult a clinician.

Interactions

warfarin and other anticoagulantsModerate

CoQ10-type compounds may slightly reduce warfarin effect; monitor INR

chemotherapy agentsModerate

antioxidants may theoretically interact with some chemotherapy

antihypertensivesMinor

possible additive effects (theoretical)

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

stated mitoquinone mesylate dose (commonly 10 mg)
reputable manufacturer with stability data

Be skeptical of

anti-aging or longevity cure claims
neurodegeneration treatment claims

Frequently asked questions

How is MitoQ different from CoQ10?

MitoQ has a positively charged 'tail' that accumulates inside mitochondria 100-1000 times more concentrated than CoQ10. Doses are much lower (mg vs. hundreds of mg for CoQ10).

Is MitoQ better than CoQ10?

It targets mitochondria more directly, but human clinical evidence is still developing. They serve somewhat different roles and direct comparisons are limited.

Will MitoQ help me feel less tired?

Some studies suggest benefits for fatigue in certain conditions, but evidence in healthy people is preliminary.

Should I take MitoQ with food?

Most clinical studies have used it on an empty stomach or with light food. There is no strong evidence for or against either approach.

Is MitoQ safe long-term?

Short-term clinical data look favorable. Long-term human safety data are still accumulating. At standard supplement doses (10 mg/day), the safety profile appears good.

References by claim

vascular function in middle-aged and older adults

Kirkman et al., 2023PubMed (2023) link

Rossman et al., 2018PMC (2018) link

mitochondrial oxidative stress

Murray et al., 2023PMC (2023) link

Moradbaki et al., 2026PubMed (2026) link

Track Mitoquinone mesylate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.